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Thiolated and PEGylated silica nanoparticle delivery to hair follicles 
Jamila H. Al Mahrooqi, Vitaliy V. Khutoryanskiy, Adrian C. Williams* 




Targeting drug delivery to hair follicles is valuable to treat conditions such as 
alopecia’s and acne, and this shunt route may also allow drug delivery to deeper 
skin layers and the systemic circulation by avoiding the intact stratum corneum. 
Here, we investigated the effects of nanoparticle surface chemistry on their 
delivery into hair follicles by synthesizing fluorescent thiolated silica nanoparticles 
and functionalizing with 750 Da and 5000 Da methoxypolyethylene glycol 
maleimide (PEG). The stability of the nanoparticles in skin homogenate was 
verified before tape stripping of porcine-dosed tissue showed the distribution of 
the free fluorescent dye and different nanoparticles in the skin. Analysis of 
microscopic images of the skin sections revealed penetration of nanoparticles 
functionalized with PEG into the appendages whereas thiolated nanoparticles 
stayed on the surface of the skin and were removed by tape stripping. 
Nanoparticles functionalized with PEG 5000 Da penetrated deeper into the hair 
follicles compared to counterparts functionalized with PEG 750 Da. PEGylation 
can thus enhance targeted delivery of nanoparticulates into hair follicles. 
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1 Introduction: 
 
The remarkable barrier properties of human skin are largely attributed to the 
outermost layer of the epidermis, the stratum corneum (Brown and Williams, 2019; 
Labouta and Schneider, 2013). Appendages including the hair follicles and eccrine 
glands cross the epidermis and originate in the underlying dermis. Given the 
stratum corneum barrier, it is well established that typically only relatively small 
molecular weight and lipophilic drugs are able to be delivered effectively via the 
transdermal route to clinically efficacious levels, though some recent studies have 
shown that macromolecules such as aptamers may be able to enter the tissue 
(Lenn et al., 2018). However, the use of nanoparticles for drug delivery into or 
through the skin has also been studied using quantum dots, carbon nanotubes, 
metal and metal oxide nanoparticles, dendrimers, and lipid based nanoparticles 
(Jensen et al., 2011; Kraeling et al., 2018; Küchler et al., 2009). 
 
Nanoparticulate dosing of skin tends to focus on two mechanisms of delivery. 
Firstly, the potential delivery of the nanosystem into intact stratum corneum (and 
deeper epidermal layers) with studies exploring the effects of physicochemical 
properties of the nanosystems including their size, shape, charges and surface 
properties (Labouta et al., 2011a; Labouta and Schneider, 2013; Lademann et al., 
2011). Other factors considered include the nanoparticle vehicle and the disease 
state of the skin or stratum corneum barrier impairment (for example during wound 
healing) (Brown and Williams, 2019; Larese et al., 2009; Vogt et al., 2016; Wu et 
al., 2009). Secondly, the nanoparticles may be delivered into the appendages 
(pilosebaceous unit and eccrine and apocrine ducts). Though varying from site to 
site (Otberg et al., 2004) the appendage openings represent approximately 0.1% 
of the skin surface area and provides a shunt route to the lower layers of the skin 
by circumventing the intact surface stratum corneum (Brown and Williams, 2019; 
Raber et al., 2014). The follicles have been targeted with nanoparticles to treat 
conditions such as alopecia and acne, and alternatively to deposit a reservoir of a 
drug to permeate into deeper skin layers or the systemic circulation. 
 
Particle deposition into a hair follicle is usually stimulated in vivo by hair movement 
and (as with in vitro studies) by massage. Further, the cuticles on the surface of 
the hair shaft form a zigzag structure which acts as a geared pump that, with hair 
movement, can push nanoparticles deeper into the hair follicles. Clearance of 
nanoparticles from the follicle depends primarily on sebum production and hair 
growth, both relatively slow processes allowing the follicle to serve as a reservoir; 
when particles were applied, their clearance from the hair follicle was over a period 
of 10 days (Knorr et al., 2009; Lademann et al., 2009; Raber et al., 2014). More 
specifically within the hair follicle, the infundibulum generally provides the reservoir 
compartment whereas sebaceous glands are associated with acne and 
androgenetic alopecia and the bulge region holds a reservoir for keratinocyte stem 
cells (Knorr et al., 2009; Patzelt et al., 2011).  
However, the optimal nanoparticle properties for deposition into hair follicles are 
unclear and variations are also seen with delivery vehicle; Mathes et al. reported 
greater follicular deposition of particles from aqueous dispersions compared to 
when suspended in a hydrogel and that follicular uptake can thus be controlled by 
the choice of vehicle or carrier used to deliver a drug (Mathes et al., 2016). Patzelt 
et al. (2011) compared the depth of penetration into hair follicles of different sizes 
(122, 230, 300, 470, 643, and 860 nm) of two types of nanoparticles, PLGA (poly-
lactide-co-glycolid) and silica. Both types showed similar size-dependent 
penetration, increasing in depth as size rose to 643 nm, but the silica nanoparticles 
penetrated deeper than the PLGA particles. It had been proposed that the geared 
pump effect from hair shaft movement is optimal when the particles are similar 
size to the hair cuticles – in the region of 500 nm (Lademann et al., 2009; Patzelt 
et al., 2011). However, Vogt et al. reported deeper penetration of 40 nm 
nanoparticles along the follicular duct of human vellus hair and through the 
follicular epithelium, whereas 750 and 1500 nm nanoparticles aggregated in the 
infundibulum with no penetration to deeper layers or through viable epidermis 
(Vogt et al., 2006). 
Varied nano-particulate systems have been evaluated for controlled drug delivery 
within hair follicles, ranging from liposomes and polymersomes to solid lipid 
nanoparticles and nano-vesicles. Commonly seeking to treat alopecias, examples 
include oleic acid and phosphatidylcholine nano-vesicles containing minoxidil 
which increased deposition of the drug in the follicles 10-fold compared to a gel 
formulation (Kumar et al., 2018).  Minoxidil has also been incorporated into 
liposomes (e.g. Jain et al., 2010), solid lipid nanoparticles (Padois et al., 2011) and 
into nanoparticles formed from PLGA (Takeuchi et al., 2018) – as has finasteride 
(Roque et al., 2017). The use of nano-sized delivery systems to target hair follicles 
in alopecia, along with consideration of the anatomy and pathophysiology of the 
condition, has recently been reviewed (Salim and Kamalasanan, 2020).  
Nanocarriers have also been used for glucocorticoids such as clobetasol 
propionate for inflammatory scalp conditions. To mitigate both systemic and local 
adverse effects when applied topically, a range of clobetasol-loaded polymeric 
nanocarriers were evaluated (nanospheres, nanocapsules, lipid-core 
nanocapsules) to balance drug release, interfollicular permeation and follicular 
uptake (Schiedel et al., 2015). Significantly greater levels of drug were found in 
the follicles from the nanocarriers compared to application of the free drug and, 
importantly, the study demonstrated that not only was the carrier important but 
also that massaging the tissue resulted in greater follicular uptake, in agreement 
with the above.  
 
PEGylation is widely used to improve stability, tolerance and delivery to various 
tissues including eyes, urinary bladder, and nasal tissue (Porfiryeva et al., 2020). 
We have previously shown that PEGylation of nanoparticles reduces their 
mucoadhesion and improves their diffusivity (Irmukhametova et al., 2011; Mun et 
al., 2014b; Mun et al., 2016; Ways et al., 2018). However, nanoparticles with thiol 
groups on their surface are expected to stay bound to the skin surface and hair as 
they are rich in keratin. Polyacrylic acid was modified with sulfhydryl moieties to 
improve its binding to the skin, resulting in a 15-fold increase in adhesion 
compared to unmodified polymer (Laffleur and Bernkop-Schnürch, 2018). 
Likewise, thiolation of silicone oil enhanced adhesion to skin in comparison to 
commonly used silicone oils (Partenhauser et al., 2016). Here, we used tape 
striping to study the follicular deposition of two types of silica nanoparticles with 
different surface chemistry and sizes, thiolated and PEGylated (750 and 5000 Da) 
silica nanoparticles. The particles were fluorescently labelled with 5-
iodoacetamido fluorescein and follicular uptake was investigated in vitro using pig 
flank skin. 
 




3-mercaptopropyltrimethoxysilane (MPTS 95%), maleimide terminated methoxy 
poly(ethylene glycol) (PEG molecular weight 750 & 5000 Da), sodium phosphate 
dibasic (≥99%), sodium phosphate monobasic dihydrate (≥99%), 5- 
(iodoacetamido)fluorescein, sodium fluorescein, and 5,5′-dithiobis(2- 
nitrobenzoic acid) (DTNB, ≥98% TLC), were purchased from Sigma-Aldrich (UK). 
DMSO, sodium hydroxide pellets and Slide-A-Lyzer minidialysis devices, 3.5kDa 
MWCO, were purchased from Fisher Scientific (UK). L-Cysteine hydrochloride 
anhydrous (98%) was purchased from Alfa Aesar (UK). Dialysis membrane with 
a molecular weight cut-off 12–14 kDa was purchased from Medicell International 
Ltd. (UK). D-Squame Standard Sampling Discs and D- Squame® disc applicator 
was purchased from Clinical and Derm (USA). All materials were used as 
received. Fresh newborn (<1 month old) pig flank skin was obtained from the 
Pirbright Institute (UK) and was frozen immediately after collection until use. 
 
2.2 Synthesis and characterization of thiolated silica nanoparticles: 
 
Thiolated silica nanoparticles were synthesised according to a previously 
published method (Irmukhametova et al., 2011). Briefly, 20 mL DMSO and 0.5 
mL of 0.5 M NaOH solution were added to 0.75 mL MPTS. The mixture was 
stirred continuously with air bubbling for 24 h at room temperature. The 
nanoparticles were purified by dialysis against deionized water (5 L, eight 
changes of water) using dialysis membrane. The purified aqueous dispersions of 
the nanoparticles were stored at 4 °C. 
 
2.3 Synthesis of fluorescently-labelled thiolated silica nanoparticles: 
 
Thiolated silica nanoparticles were labelled with 5-(iodoacetamido) fluorescein 
(5-IAF) by adding 3 mg of 5-IAF to 12 mL aqueous dispersions of thiolated 
nanoparticles. The amount of fluorophore used was calculated with respect to 
molar ratio so that 5 µmol of fluorophore is added to 50 µmol of sulfhydryl groups 
of nanoparticles. The reaction mixture was stirred for 16 h at room temperature 
protected from light. Fluorescently-labelled nanoparticles were then purified by 
dialysis against deionized water in the dark (5 L, eight changes of water), 
according to the above protocol (Irmukhametova et al., 2011). 
 
2.4 PEGylation of fluorescently-labelled nanoparticles: 
 
5 mL aqueous dispersions of fluorescently-labelled nanoparticles were mixed 
with 100 mg of methoxypolyethylene glycol maleimide of two molecular weights 
(750 or 5000 Da). The reaction mixture was stirred for 16 h at room temperature 
protected from light, resulting in the formation of PEGylated silica nanoparticles. 
PEGylated nanoparticles were purified by dialysis in the dark as above (Mun et 
al., 2014b). 
 
2.5 Characterization of nanoparticles 
 
DLS and ᶚ-potential measurements were conducted with dilute dispersions of 
nanoparticles at 25 °C using a Nano-S Zetasizer (Malvern Instruments, UK). 
Each batch of nanoparticles was synthesized in triplicate, and the analysis was 
carried out three times for each sample. The mean and standard deviation of 
particle size, polydispersity, and ᶚ-potential were calculated. The thiol group 
content in nanoparticles was determined by Ellman’s assay according to a 
previously published method (Al Mahrooqi et al., 2018). 
 
 
2.6 Stability study 
 
The stability of the fluorescent label on the nanoparticles for use in skin studies 
was evaluated by adding the nanoparticles to skin homogenate and dialysing 
against phosphate buffered saline (PBS) to assess the release of free dye. 
Briefly, 2 g of pig skin was cut into small pieces and homogenised in 15 mL of 
PBS at 6500 rpm for 1 minute in an ice bath using an Ultra Turrax T18 high speed 
homogenizer (Lau et al., 2013). Four different samples were prepared by mixing 
1.5 mL of the labelled nanoparticles, unlabelled nanoparticles, sodium 
fluorescein and homogenate respectively with 1.5 mL of homogenate (total 3 mL) 
and dialysed against PBS. The samples were placed on a rolling plate with 
continuous shaking at 37 ⁰C to ensure continuous mixing and movement of the 
dialysate. The fluorescence intensity of the dialysate was assessed using a 
fluorescent spectrophotometer after 1, 6, 24, 48, and 72 hours of incubation. The 
experiment was performed in triplicate and data were analysed using GraphPad 
Prism 8 software. 
 
2.7 Tape stripping study 
 
Pig flank skin was thawed at room temperature and hair was carefully shaved to 
avoid damaging the stratum corneum before use. Test areas were demarked 
using a permanent marker around a 2.5  2.5 cm polyethylene template. A finite 
dose of fluorescently labelled nanoparticles (50 µL, so 8 µL cm-2) was applied 
and the area gently massaged in a circular movement for one minute using a 
gloved fingertip. The dosed tissue was then left for 2 hours at room temperature, 
protected from light. D-Squame® adhesive discs were used for tape stripping; 
each disc was pressed firmly against the skin using a D- Squame® disc 
applicator with a constant pressure of 225 g/cm2 for 5 sec. The marked area was 
stripped sequentially twenty times with the direction of stripping alternating for 
each strip. After each strip, both the adhesive disc containing the removed layer 
of stratum corneum and the remaining skin sample were analysed using a Leica 
MZ10 F stereomicroscope (Leica Microsystems, UK) with an ET-GFP filter to 
quantify the presence of fluorescent nanoparticles and show their distribution. All 
images were taken with an exposure time of 80 mS, gain 2, gamma 1 and 
wavelength 520 nm. Images were further analysed using ImageJ software 
(National Institutes of Health, USA) and normalised with the following equation: 
 
         Fluorescence intensity =
𝐼− 𝐼𝑏
𝐼0− 𝐼𝑏
× 100    equation 1  
where I is the fluorescence intensity of the nanoparticle-dosed skin sample or 
disc after each tape stripping and Io is the initial fluorescence intensity of the 
sample following dosing, massage and incubation but prior to any tape stripping. 
Ib is the background fluorescence intensity of the disc or skin; to allow each 
individual tissue sample to act as its own background fluorescence control (Ways 
et al., 2018), and recognising that this may change the sequential removal of the 
stratum corneum, background fluorescence was measured after each tape 
stripping of non-dosed skin samples using the same protocol as above. 
 
In addition, each adhesive disc was weighed before and after tape stripping in 
order to determine the fraction of the barrier removed or relative depth (x/L); 
where x is the thickness removed divided by the total stratum corneum thickness 
(L) and so relative depth within the stratum corneum varies between 0 (at the 
skin surface) to 1 at the interface with the viable epidermis (Russell and Guy, 
2012). Each disc was then centrifuged in 5 mL PBS at 3500 rpm for 10 minutes 
before the fluorescence intensity of the extract was assayed using a fluorescence 
spectrophotometer (Cary Eclipse, Varian Inc., US) at 494 nm excitation and an 
emission spectral range of 500 - 600 nm. 
 
The tape stripped skin area was then excised and placed on a weighing boat with 
the epidermis facing upwards and fully covered with OCT embedding medium 
and placed in dry ice. The frozen sample was stored at -80 ⁰C before tissue cross 
sectioning at -20 ⁰C using a Bright 5040 cryostat microtome (Bright Instruments 
Ltd., Luton, UK). Tissue was placed perpendicularly to the cutting blade (i.e. 
tissue cut from dermis to outer surface) to avoid dislocation of the nanoparticles 
from outside into deeper skin layer (Labouta et al., 2011a, 2011b). Cross-
sections (10 µm) were placed on microscopic slides and imaged using a Zeiss 
Axio Imager fluorescence microscope (Carl Zeiss, Jena, Germany). The samples 
were excited with a 488 nm filter in order to locate the labelled nanoparticles and 
with a DAPI filter to view the tissue. The two images were merged using Carl 
Zeiss software and analysed by ImageJ software. 
 
 
3 Results and discussion: 
 
3.1 Synthesis and characterization: 
 
Thiolated silica nanoparticle were synthesized by hydrolysis and self- 
condensation of 3-mercaptopropyltrimethoxysilane (MPTS) in the aprotic solvent 
dimethyl sulfoxide (DMSO) in contact with air, with NaOH as the catalyst. Sub-
100 nm cross-linked nanoparticles are formed through Si-O-Si and disulfide 
bonds. The nanoparticles were labelled with 5-IAF, where the iodoacetamide 
moiety of the fluorophore reacts with the sulfhydryl group in the nanoparticles. 
Fluorescently labelled nanoparticles were then PEGylated and both labelled 
thiolated and PEGylated silica nanoparticles were used in all experiments. It has 
been reported that a high grafting density of lower molecular weight PEG and 
decorating particles with PEG 5000 Da provide rapid mucus penetrating 
properties, whereas, nanoparticles became mucoadhesive when coated with 
PEG 10000 Da (Wang et al., 2008). Therefore, PEG 750 and 5000 Da were 
chosen for our experiments. 
The resulting nanoparticles significantly (P < 0.05) increased in size in the order 
thiolated < PEGylated 750 Da < PEGylated 5000 Da and they all had a narrow 
polydispersity index (PDI; Table 1 and Figure S1) and negative ᶚ- potential 
values due to the presence of thiol groups at their surface. Following PEGylation, 
the nanoparticles’ ᶚ- potential values reduced due to the polymer coupling with 
some of the free thiol on the surface of the nanoparticles, with the greater 
decrease seen for the larger molecular weight PEG also partially attributed to 
some charge shielding effects. Indeed, the Ellman’s assay showed a statistically 
significant (P<0.005) difference in free thiol content between thiolated and the 
PEGylated nanoparticles, and no significant difference between PEGylated 750 
and 5000 Da particles. The reduction in thiol content and increase in particle size 
indicates successful PEGylation of the nanoparticles (Table 1), but clearly these 
particles retain some free thiol groups at their surface – approximately 50% of 
those seen in the parent thiolated material. Nanoparticle concentrations were 
determined by freeze-drying 1 mL of nanoparticle suspensions and determining 
the weight of the solid residue. This concentration was used to calculate free thiol 








Free thiol content 
(µmol/g)* 
Thiolated 62 ± 3 0.207 ± 0.015 -47 ± 3 15 ± 1 289 ± 14 
PEGylated 750 Da 79 ± 1 0.214 ± 0.011 -42 ± 3 12 ± 1 144 ± 21 
PEGylated 5000 Da 89 ± 1 0.169 ± 0.010 -30 ± 2 20 ± 2 142 ± 2 
 
Table 1: Characterization of thiolated and PEGylated silica nanoparticles, n=3, values presented as 




3.2 Stability of nanoparticles in skin homogenate: 
 
The skin possesses both enzymatic and non-enzymatic detoxification systems 
including glutathione (GSH) as an antioxidant (Connor and Wheeler, 1987) which 
acts as a direct free radical scavenger and quenches radicals by hydrogen atom 
donation resulting in the formation of glutathione disulphide (GSSG). However, as 
the reduced form of GSH is essential for cutaneous photo-protection, GSSG is 
recycled to GSH by GSH-reductase with hydrogen donation by nicotinamide 
adenine dinucleotide phosphate (NADPH). This process is extremely fast due to 
the high activity of the enzyme and it takes less than one minute to restore all 
cutaneous GSH (Connor and Wheeler, 1987). It was anticipated that nanomaterials 
with disulfide bonds are susceptible to degradation by GSH (Cui et al., 2012; 
Hayashi et al., 2016; Prasetyanto et al., 2016; Yang et al., 2016; Zhang et al., 2012; 
Zhou et al., 2017), and so the stability of the fluorescent label attached to the 
nanoparticle core before further decoration with PEG was investigated in skin 
homogenate.  The release of fluorescent dye from the fluorescent thiolated silica 
nanoparticles was examined in the phosphate buffer (“labelled TSNP’s”) and in 
skin homogenate, alongside assays of sodium fluorescein with skin homogenate 
as a positive control and the homogenate alone to detect auto-fluorescence; the 
homogenate showed no detectable auto- fluorescence during the study. The 
release of the fluorophore was measured over time (Figure 1) and sodium 
fluorescein was detected in the dialysate at 6 hours (4%) and reached (11%) at 72 
hours. The labelled particles showed a similar release profile when incubated in 
either buffer of skin homogenate with very low fluorescence first detected after 24 
hours and no significant differences in release in these two media (p > 0.05). 
Release of sodium fluorescein across the dialysis membrane from the positive 




Figure 1: The release of fluorescent dye across the dialysis membrane. Labelled TSNP = 
fluorophore release from labelled silica nanoparticles in buffer; Homogenate = homogenate alone 
to test for autofluorescence; Homogenate/TSNP’s = fluorophore release from labelled silica 
nanoparticles in skin homogenate; Homogenate/Sodium fluorescein is the positive control of the 
fluorescent dye with homogenate. Study at 37 ⁰C, samples taken at 1, 6, 24, 48, 72 hours, n=3, 




Doura et al. (2019) demonstrated that MPTS nanoparticles were resistant to GSH-
induced degradation and retained their spherical shape. In their experiments, they 
prepared various hybrid thiol-organosilica nanoparticles from different proportions 
of 3-mercaptopropyltrimethoxysilane (MPTS) and 3- 
mercaptopropyldimethoxymethylsilane (MPDMS) and detected the ratio of 
disulphide bonds to thiol groups in each sample by Raman spectroscopy. They 
investigated the degradability of the nanoparticles in 10 and 40 mM of GSH, 
compared with nanoparticles prepared from MPTS or MPDMS alone. They found 
that increasing the ratio of MPDMS increased the susceptibility to degradation by 
GSH. They also found that the introduction of MPDMS into nanoparticles prepared 
from MPTS induced the formation of disulfide bonds which was proportional to the 
ratio of MPDMS constituent (Doura et al., 2019). In our study, the particles 
produced from MPTS likewise showed no significant degradation in the skin 
homogenate. Further, both labeled and unlabeled nanoparticles were stored for up 
to 6 months and no flocculation or aggregation was observed, again in agreement 
with previous studies using similar nanoparticles (Ways et al., 2018). 
 
 
3.3 Tape stripping study: 
 
Equation 1 was used to quantify the fluorescence intensity of the skin and tape 
strips, and relies on subtraction of background fluorescence (Ib). Prior to dosing, 
we investigated the effects or tape stripping skin on the background fluorescence 
of the tissue. The experiments (in triplicate) showed a gradual reduction in the 
background intensity with tape stripping such that after 20 strips, the background 
intensity had fallen by a mean of 12%. These values were used for the background 
intensities in subsequent dosed studies. 
Tape stripping is increasingly used for bioavailability and bioequivalence studies 
(Herkenne et al., 2008; Pensado et al., 2019). However, specific study protocols 
vary, for example in cutting or shortening the hair prior to experimentation (Jensen 
et al., 2011; Klang et al., 2011; Nagelreiter et al., 2015; Patzelt et al., 2011). Here, 
the hair was shaved since preliminary studies showed that our nanoparticles bound 
strongly to shortened hair bristles even after 20 tape stripping (Figure S3 a) but 
binding was reduced with PEGylated nanoparticles (Figure S3 b &c). Keratin is rich 
in disulfide bonds and thiolated silica nanoparticles interact covalently with hair 
keratin (Bragulla and Homberger, 2009; Cruz et al., 2017; Gniadecka et al., 1998; 
Williams et al., 1994). PEGylation of the thiolated particles reduces the free thiol 
groups in the particle shell by about 50% (Table1) and may also screen remaining 
thiol groups on the particle surface. A similar trend with mucoadhesion to different 
tissues was reported where mucoadhesive properties of the thiolated silica 
nanoparticles were significantly decreased by PEGylation and penetration was 
improved (Irmukhametova et al., 2011; Mun et al., 2014b; Ways et al., 2018). 
Significant reductions (P<0.05) in fluorescence intensity of all tested nanoparticles 
and sodium fluorescein was evident after 2 hours of incubation on the skin surface 
and prior to tape stripping. The fluorescence intensity reduced to 12, 52, 7 and 10% 
for sodium fluorescein, TSNPs, PEGylated 750 Da and PEGylated 5000 Da TSNPs 
respectively which could be attributed to quenching of fluorescein (Glasgow, 2016; 
Song et al., 1995) and penetration into the follicles. Teichmann et al. reported 
recovery of 95% of sodium fluorescein dye from stratum corneum and 5% from 
follicular infundibula after differential stripping (Teichmann et al., 2005). The 
penetration of sodium fluorescein solution into stratum corneum has also been 
compared with that when loaded into PEGylated lipid nanocarriers (Rangsimawong 
et al., 2016). In another study, Zhang et. al. used transmission electron microscopy 
to study PEG-coated quantum dots applied to skin and reported localization within 
the lipid bilayers of the stratum corneum. This was attributed to the soft coating of 
PEG which enabled the quantum dots to enter the intercellular lipid matrix of the 
stratum corneum although this is unlikely the case for our larger PEGylated 
nanoparticles (Zhang et al., 2008). It is notable that a far larger proportion of the 
fluorescence remained at the skin surface 2 hours post-dosing of the thiolated silica 
nanoparticles (prior to tape stripping). Fourier transform Raman and infrared 
vibrational analysis of the stratum corneum demonstrated the presence of 
disulphide bonds in proteins (Barry et al., 1992; Gniadecka et al., 1998) and the 
keratins that form the stratum corneum are relatively soft and contain little cysteine 
compared to hair (Williams et al., 1994). Retention of the thiolated silica 
nanoparticles on the skin surface is thus likely attributable to the formation of 
disulphide bonds with the outer hair shaft and, to a lesser extent, stratum corneum 
keratins. 
We used spectroscopic and gravimetric analysis to generate nanoparticle 
distribution profiles as a function of stratum corneum depth (Figure S4). By 
assuming that the density of stratum corneum and area stripped are constant and 
knowing the weight of stratum corneum removed, the mass of sample removed 
can be related to tissue depth (Higo et al., 1993). The distribution profiles only 
showed significant differences between thiolated silica nanoparticles and sodium 
fluorescein (p < 0.05) and no significant differences between either of the 
PEGylated particles or the thiolated material (Figure 2). Sodium fluorescein has 
been reported to readily penetrate into the stratum corneum but less well into the 
deeper layers of the epidermis (Rangsimawong et al., 2016). Here, we see a 
reproducible penetration gradient down to approximately 60% of the stratum 
corneum thickness for the free dye (Figure 2). In contrast, there is no strong 
evidence for penetration of any of the nanoparticles into the intact stratum corneum 
with almost all particles removed by the second tape strip. Some fluorescence was 
seen but is attributed to particles remaining bound to the surface of the skin, held 
in skin furrows or adhered to the upper hair follicle and so were not removed by 





Figure 2: Penetration depth of sodium fluorescein, TSNPs, PEGylated (750 & 5000 Da) TSNPs into the 
removed stratum corneum layers, n=3, P < 0.05, values are presented mean ±standard error of mean 
calculated using one-way ANOVA and Bonferroni post-hoc tests 
 
Fluorescent microscope images of skin sections were taken to visualize the location 
of nanoparticles and clearly demonstrated their binding to hair follicles (Figure 3). The 
thiolated silica nanoparticles (Figure 3a) can be seen to adhere to the skin surface and 
external surface of the hair follicle as well as reside in a skin furrow. The images show 
no evidence for penetration into the deeper skin layers, in agreement with the results 
obtained from the tape strips. Sodium fluorescein penetrated into the hair follicles and 
analysis of the skin section images revealed a mean maximal penetration depth of 700 
µm (Figure 3b). PEGylated nanoparticles penetrated into the hair follicles to a mean 
maximal depth of 450 µm and 1400 µm for PEGylated 750 Da (Figure 3c) and 5000 






Figure 3: Exemplar fluorescence microscope images of tape stripped pig skin sections (10 µm thick) after 
application of thiolated nanoparticles (a), sodium fluorescein (b), PEGylated 750 Da nanoparticles (c) and 
PEGylated 5000 Da nanoparticles (d). For each set, the first image uses an Alexa 488 nm (green) filter to 
show only the nanoparticles and the second image merges this with a DAPI (blue) filter to visualise the 
nanoparticles with the skin background. Scale bar 100 µm. 
 
 
Analysis of the images (12 images for each sample with three measurements for each 
image) revealed significant differences in particle penetration into the hair follicles with 
PEGylated 5000 Da nanoparticles penetrating deepest followed by sodium 
fluorescein, PEGylated 750 Da nanoparticles and the fully thiolated materials 










Figure 4: Depth of penetration into the hair follicles, n=12, all results are significantly different from each 
other (P <0.0005), values are presented mean ±standard error of mean calculated using one-way ANOVA 
and Bonferroni post-hoc tests. 
 
Sodium fluorescein is a low molecular weight compound (376 Da) that was shown 
above to penetrate into the stratum corneum, in accord with literature reports. This 
water-soluble dye was also reproducibly seen at a depth of 700 µm within the follicles, 
in the infundibulum and in the region of the sebaceous gland; Knorr et al. and Patzelt 
et. al. reported that the sebaceous gland is located ~ 600 µm to 900 µm deep within 
the terminal hair follicle (Knorr et al., 2009; Patzelt et al., 2011). As expected, the 
thiolated particles penetrated least well into the follicles, again attributed to their 
binding to keratin of the hair. PEGylation of these particles enhanced their deposition 
into the follicles compared to the parent thiolated materials with the PEG 750 
nanoparticles penetrating to a mean maximal depth of 450 µm, again in the 
infundibulum above the sebaceous gland. However, the particles decorated with larger 
molecular weight PEG penetrated deeper, to 1400 µm and close to the bulge region 
of the hair follicle (Vogt et al., 2007). 
 
Others have similarly demonstrated the value of PEGylation for enhancing drug 
delivery. A silica core/PEG shell nanocomposite promoted uptake into MCF-7 breast 
cancer cells (Slowing et al., 2007). Liposomes loaded with calcipotriol were coated 
with variable concentrations of PEG to enhance their stability and increased 
penetration into the skin in comparison to non-PEGylated counterparts. Whilst PEG 
increased hydration of the stratum corneum by binding to water molecules resulting in 
enhanced permeability of the stratum corneum, variability in penetration of PEG 
coated calcipotriol liposomes was also attributed to the PEG conformation on the 
liposome surface (Knudsen et al., 2012). Deposition of gold nanorods decorated with 
PEG has also been studied in skin (Mahmoud et al., 2017) and were shown to 
penetrate into the follicular compartments but to a lesser extent than hydrophobic gold 
nanorods. However, after 24 hours, accumulation of PEGylated gold nanorods in 
deeper skin layers was significantly higher than for other gold nanorod systems with 
the authors suggesting that trans-follicular diffusion was facilitated by the polymers 
hydrophilic properties. 
 
Our results illustrate that deposition into hair follicles is not solely by passive diffusion. 
Both the free dye and the PEGylated particles are hydrophilic and so diffusion theory 
would predict that the small molecular weight free drug would diffuse considerably 
faster than the nanoparticles. Penetration of the particles into the hair follicles is 
stimulated by movement of the hair, achieved by massaging the tissue in this study. 
The geared pump effect from hair shaft movement, described earlier, can carry 
particles deep within the follicle and it is notable that our largest nanoparticles, with 
PEG 5000 (89 nm diameter), penetrated deeper than the smaller PEG 750 material 
(79 nm diameter); it was suggested that particles closest in size to the hair cuticles 
~500 nm) would be driven deepest into the follicles (Lademann et al., 2009; Patzelt et 
al., 2011). Further, upwards flow of sebum secreted from sebaceous gland can act as 
both a physical and chemical barrier for nanoparticle diffusion (Knorr et al., 2009; 
Lademann et al., 2009). Though this study used excised skin, it is likely that residual 
sebum within the follicle provided an additional hydrophobic barrier to penetration of 
the dye and particles. 
 
The significantly different penetration depths of the two PEGylated particles are 
unlikely to result solely from the differences in their sizes. We have previously studied 
the diffusion of these nanoparticles in aqueous polymer solutions and water (Mun et 
al., 2014a). As expected, factors affecting diffusion of the nanoparticles were their size, 
the medium viscosity and the presence of interactions between the nanoparticles and 
the medium components. PEGylating nanoparticles enhanced their diffusivity in pure 
water, despite the size increase caused by functionalization, and this was attributed to 
the lubricating effect of PEG shell. PEGylation also reduced nanoparticle 
mucoadhesion to various tissues including the eye, the urinary bladder and nasal 
mucosa, again due a reduction in the exposed thiol groups on the particle surface 
which reduced binding, as seen here (Irmukhametova et al., 2011; Mun et al., 2014b; 
Ways et al., 2018). With reduced binding capacity, these particles also penetrated 
deeper in tissue. It was reported that PEG < 2000 Da forms short chains with loss of 
flexibility compared to when molecular weight is > 2000 Da (Owens and Peppas, 
2006). In our studies, PEG forms a soft shell on the surface of the nanoparticles which 
reduces the number of thiol groups exposed to bind with keratin and so facilitates 
particle penetration into the hair follicles. Moreover, deeper penetration into the 
follicles of the PEGylated 5000 Da nanoparticles compared to 750 Da PEG particles 
is due to the greater flexibility and length of PEG chains which can further enclose and 








This study has demonstrated that nanoparticles can be designed to penetrate to 
defined depths within hair follicles. Thiolated nanoparticles bind to keratin and are 
localized on the skin surface and near to the skin surface in the hair follicle. When 
decorated with polyethylene glycol, approximately half the thiol groups are removed 
from the particle surface and so binding to keratin is greatly reduced. Nanoparticles 
functionalized with higher molecular weight PEG (5000 Da) penetrated deeper into the 
follicles, to near the bulge region, than those with lower molecular weight PEG (750 
Da) on their surface. The longer PAG chains are more flexible than their shorter 
counterparts and are better able to shield the remaining thiol groups on the particle 
surface and so allows deeper penetration by reducing particle-tissue binding. By 
manipulating the length of the PEG chain, it is feasible to targeted drug delivery to 
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